Millennium Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Sell
25,315
-18,354
-42% -$170K ﹤0.01% 5242
2025
Q4
$535K Buy
+43,669
New +$714K ﹤0.01% 4898
2025
Q3
Sell
-17,593
Closed -$238K 6339
2025
Q2
$238K Sell
17,593
-73,013
-81% -$799K ﹤0.01% 5282
2025
Q1
$785K Buy
+90,606
New +$554K ﹤0.01% 4528
2024
Q4
Sell
-45,637
Closed -$352K 6318
2024
Q3
$352K Buy
45,637
+28,317
+163% +$252K ﹤0.01% 5099
2024
Q2
$173K Sell
17,320
-42,586
-71% -$468K ﹤0.01% 5192
2024
Q1
$728K Sell
59,906
-10,025
-14% -$145K ﹤0.01% 4555
2023
Q4
$1M Sell
69,931
-67,704
-49% -$650K ﹤0.01% 4168
2023
Q3
$1.07M Sell
137,635
-43,165
-24% -$470K ﹤0.01% 4137
2023
Q2
$2.58M Sell
180,800
-149,563
-45% -$2.13M ﹤0.01% 3252
2023
Q1
$4.83M Buy
330,363
+275,530
+502% +$4.61M ﹤0.01% 2632
2022
Q4
$921K Sell
54,833
-256,362
-82% -$4.43M ﹤0.01% 4246
2022
Q3
$4.61M Buy
+311,195
New +$6.15M ﹤0.01% 2973
2022
Q1
Sell
-9,384
Closed -$583K 7321
2021
Q4
$583K Sell
9,384
-579,407
-98% -$43.9M ﹤0.01% 4915
2021
Q3
$50.4M Buy
+588,791
New +$36.9M 0.03% 635
2021
Q2
Sell
-10,544
Closed -$514K 6933
2021
Q1
$514K Buy
+10,544
New +$509K ﹤0.01% 4804
2019
Q3
Sell
-25,559
Closed -$414K 4451
2019
Q2
$414K Sell
25,559
-72,516
-74% -$979K ﹤0.01% 3359
2019
Q1
$1.25M Buy
98,075
+45,485
+86% +$591K ﹤0.01% 2722
2018
Q4
$577K Sell
52,590
-32,373
-38% -$479K ﹤0.01% 2873
2018
Q3
$1.53M Buy
+84,963
New +$1.07M ﹤0.01% 2622

Other funds holding OPRX

Millennium Management's OPRX Position: Q1 2026 in Review

Millennium Management reduced its OptimizeRx (OPRX) stake by 42% in Q1 2026, selling an estimated $170K and leaving 25,315 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #5242.

Millennium Management first reported a position in OPRX in Q3 2018 and has held it in 20 quarters since. The position peaked at $50.4M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Millennium Management held 25,315 shares of OptimizeRx worth $159K as of Q1 2026.
  • Millennium Management sold 18,354 OptimizeRx shares in Q1 2026, an estimated $170K.
  • OptimizeRx made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5242 holding.
  • Millennium Management first reported a position in OptimizeRx in Q3 2018 and has held it in 20 quarters since.
  • Millennium Management's OptimizeRx position peaked at $50.4M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.